How Much Did NephroPlus Raise?
Funding & Key Investors

NephroPlus, the preeminent dialysis provider network in India, has successfully solidified its market position through a series of high-impact capital infusions. The company's financial trajectory, culminating in a $101.8M strategic investment, underscores its critical role in the healthcare infrastructure sector. With a cumulative backing of $155.1M, the organization has demonstrated a consistent ability to attract institutional support, facilitating its mission to provide high-quality, patient-centric renal care across the region.

The firm's growth narrative is defined by a disciplined expansion strategy, moving from its initial Series A round in 2011 to its most recent Series F financing. This progression reflects a maturation from a specialized service provider to a dominant enterprise-level entity, capable of navigating complex regulatory and operational landscapes while maintaining service excellence.

What is NephroPlus?

NephroPlus
Hospitals & Physicians ClinicsMedical Practice ManagementMedical & Surgical Hospitals

NephroPlus operates as India's largest network of dialysis centers, fundamentally transforming the delivery of renal care. By prioritizing clinical quality and patient experience, the company has successfully mitigated the traditional stressors associated with chronic kidney disease management. Its market position is characterized by a robust operational footprint and a commitment to standardized, high-quality care protocols that have set a benchmark for the industry. The company leverages advanced medical technology and a scalable service model to address the growing demand for accessible dialysis solutions, effectively bridging the gap between clinical necessity and patient convenience.

How much funding has NephroPlus raised?

NephroPlus has raised a total of $155.1M across 5 funding rounds:

2011

Series A

$4.3M

2014

Series B

$10M

2016

Series C

$15M

2021

Series E

$24M

2024

Series F

$101.8M

Series A (2011): $4.3M with participation from Bessemer Venture Partners

Series B (2014): $10M led by Bessemer Venture Partners and International Finance Corporation

Series C (2016): $15M supported by SeaLink Capital Partners and International Finance Corp

Series E (2021): $24M featuring Investcorp, IIFL Asset Management, and Bessemer Venture Partners

Series F (2024): $101.8M backed by Quadria Capital Investment Management

Key Investors in NephroPlus

Quadria Capital Investment Management

A leading private equity firm based in India and Singapore, focused on transforming healthcare in Asia through strategic investments in scalable healthcare companies.

Bessemer Venture Partners

A prominent venture capital firm with a long-standing history of supporting high-growth companies across diverse sectors, including healthcare and technology.

International Finance Corporation

A multilateral financial institution dedicated to mobilizing capital and expertise for sustainable development and private sector growth in emerging markets.

What's next for NephroPlus?

Following the latest capital injection, NephroPlus is positioned to accelerate its strategic initiatives, likely focusing on geographic expansion and the integration of next-generation renal care technologies. The company's ability to secure major enterprise-level funding suggests a focus on deepening its market penetration and enhancing its digital health infrastructure. As the firm continues to scale, the emphasis will likely remain on operational efficiency and the maintenance of its high-quality care standards, ensuring that it remains the preferred partner for both patients and healthcare stakeholders in the evolving Asian medical landscape.

See full NephroPlus company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Hospitals & Physicians Clinics industry

Hospitals & Physicians ClinicsMedical & Surgical Hospitals
Hospitals & Physicians ClinicsPhysicians ClinicsMedical Practice Management
Hospitals & Physicians ClinicsPhysicians ClinicsMedical Practice Management
Dental Practice ManagementHospitals & Physicians Clinics

Frequently Asked Questions Regarding NephroPlus Financial Insights

What are the most recent funding rounds that NephroPlus has completed, and what were the funding rounds?
NephroPlus has recently completed 3 funding rounds: Series F on May 6, 2024, Series E on Dec 13, 2021, Series C on Aug 23, 2016.
What is the total amount of funding NephroPlus has raised to date?
NephroPlus has raised a total of $155.1M in funding to date.
How many funding rounds has NephroPlus completed?
NephroPlus has completed 3 funding rounds.
How much funding did NephroPlus raise in its most recent funding round?
NephroPlus raised $101.8M in its most recent funding round.
Who are the lead investors in NephroPlus's latest funding round?
The lead investor in NephroPlus's latest funding round was Quadria Capital Investment Management. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in NephroPlus's history?
The largest funding round in NephroPlus's history was $101.8M.
See more information about NephroPlus